866 related articles for article (PubMed ID: 29685385)
1. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
[TBL] [Abstract][Full Text] [Related]
2. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
3. The short- and long-term outcomes of percutaneous intervention with drug-eluting stent vs bare-metal stent in saphenous vein graft disease: An updated meta-analysis of all randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Ahmed S; Bachuwa G; Hassan M
Clin Cardiol; 2018 May; 41(5):685-692. PubMed ID: 29749621
[TBL] [Abstract][Full Text] [Related]
4. Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.
Patel NJ; Bavishi C; Atti V; Tripathi A; Nalluri N; Cohen MG; Kini AS; Sharma SK; Dangas G; Bhatt DL
Circ Cardiovasc Interv; 2018 Nov; 11(11):e007045. PubMed ID: 30571204
[TBL] [Abstract][Full Text] [Related]
5. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
6. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
[TBL] [Abstract][Full Text] [Related]
7. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.
Ybarra LF; Ribeiro HB; Pozetti AH; Campos CA; Esper RB; Lemos PA; Lopes AC; Kalil-Filho R; Ellis SG; Ribeiro EE
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E856-63. PubMed ID: 23239630
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive meta-analysis of randomized controlled trials comparing drug-eluting stents with bare-metal stents in saphenous vein graft interventions.
Shah R; Jovin IS; Latham SB; Hesterberg K; Heckle MR; Rashid A; Vetrovec GW
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1229-1236. PubMed ID: 30051628
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.
Mosleh W; Gandhi S; Elsiddig M; Schwalm JD; Farkouh ME
J Invasive Cardiol; 2016 Dec; 28(12):E139-E169. PubMed ID: 27845875
[TBL] [Abstract][Full Text] [Related]
10. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials.
Alam M; Bandeali SJ; Virani SS; Jneid HM; Shahzad SA; Ramanathan KB; Kar B; Kleiman NS; Lakkis N
Clin Cardiol; 2012 May; 35(5):291-6. PubMed ID: 22488047
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial.
Brilakis ES; Banerjee S; Edson R; Shunk K; Goldman S; Holmes DR; Bhatt DL; Rao SV; Smith MW; Sather M; Colling C; Kar B; Nielsen L; Conner T; Wagner T; Rangan BV; Ventura B; Lu Y; Holodniy M; Shih MC
Clin Cardiol; 2017 Nov; 40(11):946-954. PubMed ID: 28841230
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
[TBL] [Abstract][Full Text] [Related]
14. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials.
Nairooz R; Saad M; Dhillon AS; Yousaf H; Awar L; Mehra A; Matthews RV; Shavelle D; Clavijo L
Cardiovasc Revasc Med; 2018 Dec; 19(8):951-955. PubMed ID: 30078629
[TBL] [Abstract][Full Text] [Related]
17. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
[TBL] [Abstract][Full Text] [Related]
18. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
Philip F; Stewart S; Southard JA
Catheter Cardiovasc Interv; 2016 Jul; 88(1):38-48. PubMed ID: 26916633
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis.
Sanchez-Recalde A; Jiménez Valero S; Moreno R; Barreales L; Lozano I; Galeote G; Martín Reyes R; Calvo L; Lopez-Sendon JL
EuroIntervention; 2010 May; 6(1):149-60. PubMed ID: 20542811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
